ArcticZymes Technologies Initiates Share Buyback to Support Employee Share Purchase Program

25 Nov 2025 08:00 CET

Tromsø, Norway, November 25[th], 2025 - ArcticZymes Technologies ASA (OSE: AZT)
has decided to initiate a share buyback program pursuant to the authorization
granted by the Annual General Meeting held on 27 May 2025

The purpose of the program is to settle share-based incentive programs for
employees and management where employees can acquire shares at 15% discount from
market price.

The buyback will be carried out in accordance with Article 5 of the EU Market
Abuse Regulation (MAR) and Commission Delegated Regulation (EU) 2016/1052, which
provides a "safe harbour" from market manipulation rules for legitimate share
repurchase program.

The parameters for the program are as follows:

· Maximum number of shares to be acquired: 31,365 shares
· Maximum total consideration: NOK 3.1 million
· Purchase price per share shall be between NOK 1.00 and NOK 100.00
· The program will be carried out during the period from 25 November 2025 to 5
December 2025
· The repurchases will be made on the Oslo Stock Exchange and will be executed
by DNB Carnegie, a part of DNB Bank ASA, independently of the Company.

The Company will publish information about transactions carried out under the
program in accordance with applicable regulations.

The authorization granted by the General Meeting allows the Board of Directors
to acquire up to 5% of the Company's share capital, with a nominal value per
share of NOK 1.00 per share.

This information is made public pursuant to the EU Market Abuse Regulation and
subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian
Securities Trading Act.

For more information, please contact:

ArcticZymes Technologies ASA
CEO, Michael B. Akoh Tel: +46 (0) 70 262 37 15
CFO, Børge Sørvoll Tel +47 952 90187
ir@arcticzymes.com

About ArcticZymes Technologies ASA

Headquartered in Tromsø, Norway, ArcticZymes Technologies ASA is a publicly
listed, leading provider of novel and high-quality enzymes for use in molecular
research, diagnostics, and biomanufacturing. With over 30 years of expertise,
the company develops and manufactures salt-active nucleases and other specialty
enzymes inspired by the Arctic environment, enabling robust performance under
demanding process conditions. ArcticZymes is certified to ISO 13485 and
manufactures under relevant ICH GMP standards.
For more information, visit www.arcticzymes.com.

More information:
Access the news on Oslo Bors NewsWeb site

660462_AZT_Share_buy_back_for_employees.pdf